The AusDiab study, coordinated by the Baker Heart and Diabetes Institute, gratefully acknowledges the generous support given by:
- National Health and Medical Research Council (NHMRC)
- Australian Government Department of Health and Ageing
Abbott Australasia
Alphapharm
Amgen Australia
AstraZeneca
Australian Institute of Health and Welfare
Australian Kidney Foundation
Aventis Pharmaceutical
Bio-Rad Laboratories
Bristol-Myers Squibb Pharmaceuticals
City Health Centre-Diabetes Service-Canberra
Department of Health - New South Wales
Department of Health - South Australia
Department of Health - Western Australia
Department of Health and Community Services, Northern Territory
Department of Health and Human Services, Tasmania
Department of Human Services, Victoria
Department of Human Services, South Australia
Diabetes Australia
Diabetes Australia (Northern Territory)
Eli Lilly Australia
Estate of the Late Edward Wilson
GlaxoSmithKline
Impeto Medical
Jack Brockhoff Foundation
Janssen-Cilag
Kidney Health Australia
Marian & E.H. Flack Trust
Menzies Research Institute, Hobart
Merck Lipha s.a.
Merck Sharp & Dohme
Novartis
Novo Nordisk
Pfizer
Pharmacia and Upjohn
Pratt Foundation
Roche Diagnostics
Royal Prince Alfred Hospital, Sydney
Sanofi Aventis
Sanofi Synthelabo
Servier Laboratories
Queensland Health
Tasmanian Department of Health and Human Services
Victorian Government's OIS Program